相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Lakshmi Nayak et al.
CLINICAL CANCER RESEARCH (2021)
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
Katrin Aslan et al.
NATURE COMMUNICATIONS (2020)
Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
Ekaterina Friebel et al.
CELL (2020)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
Jasneet Kaur Khalsa et al.
NATURE COMMUNICATIONS (2020)
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
Ying Jing et al.
NATURE COMMUNICATIONS (2020)
Fate mapping via CCR2-CreER mice reveals monocyte-to-microglia transition in development and neonatal stroke
Hong-Ru Chen et al.
SCIENCE ADVANCES (2020)
Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020
Shruti Gupta et al.
KIDNEY360 (2020)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
Mauro Di Pilato et al.
NATURE (2019)
Rational design of anti-GITR-based combination immunotherapy
Roberta Zappasodi et al.
NATURE MEDICINE (2019)
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Maisa C. Takenaka et al.
NATURE NEUROSCIENCE (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Adverse Events Following Cancer Immunotheraoy: Obstacles and Opportunities
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery
Minako Ito et al.
NATURE (2019)
Tumor-infiltrating human CD4(+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
Mojgan Ahmadzadeh et al.
SCIENCE IMMUNOLOGY (2019)
FoxP3 scanning mutagenesis reveals functional variegation and mild mutations with atypical autoimmune phenotypes
Ho-Keun Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The function and dysfunction of memory CD8+ T cells in tumor immunity
James L. Reading et al.
IMMUNOLOGICAL REVIEWS (2018)
Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma
Dipongkor Saha et al.
IMMUNOTHERAPY (2018)
Tissue-resident memory T cells at the center of immunity to solid tumors
Derk Amsen et al.
NATURE IMMUNOLOGY (2018)
Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR
David Zemmour et al.
NATURE IMMUNOLOGY (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Comparative transcriptome analysis reveals distinct genetic modules associated with Helios expression in intratumoral regulatory T cells
Kathleen Yates et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4+ and CD8+ T cell responses
Il-Kyu Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Pakawat Chongsathidkiet et al.
NATURE MEDICINE (2018)
Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models
Vassilis Genoud et al.
ONCOIMMUNOLOGY (2018)
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8(+) T cell dysfunction and maintain memory phenotype
Bei Wang et al.
SCIENCE IMMUNOLOGY (2018)
Relationship between CD4 Regulatory T Cells and Anergy In Vivo
Lokesh A. Kalekar et al.
JOURNAL OF IMMUNOLOGY (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A positive-feedback loop between tumour infiltrating activated Treg cells and type 2-skewed macrophages is essential for progression of laryngeal squamous cell carcinoma
Wei Sun et al.
BRITISH JOURNAL OF CANCER (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Abigail E. Overacre-Delgoffe et al.
CELL (2017)
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
Vasileios Askoxylakis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment
Vasileios Askoxylakis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression
Henrik N. Kloverpris et al.
IMMUNITY (2016)
CD4+ T cell anergy prevents autoimmunity and generates regulatory T cell precursors
Lokesh A. Kalekar et al.
NATURE IMMUNOLOGY (2016)
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
Teresa E. Peterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Jonas Kloepper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Instability of Helios-deficient Tregs is associated with conversion to a T-effector phenotype and enhanced antitumor immunity
Hidetoshi Nakagawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
Abhishek D. Garg et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Understanding the Role of T Cells in CNS Homeostasis
Erik Ellwardt et al.
TRENDS IN IMMUNOLOGY (2016)
Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
Mira A. Patel et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Efficient entry of cell-penetrating peptide nona-arginine into adherent cells involves a transient increase in intracellular calcium
Kamran Melikov et al.
BIOCHEMICAL JOURNAL (2015)
Stable inhibitory activity of regulatory T cells requires the transcription factor Helios
Hye-Jung Kim et al.
SCIENCE (2015)
CD39 Expression Identifies Terminally Exhausted CD8+ T Cells
Prakash K. Gupta et al.
PLoS Pathogens (2015)
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2015)
Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
S. Han et al.
BRITISH JOURNAL OF CANCER (2014)
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Manuel Valiente et al.
CELL (2014)
Immunocompetent murine models for the study of glioblastoma immunotherapy
Taemin Oh et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
Tooba A. Cheema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Human Regulatory T Cells Kill Tumor Cells through Granzyme-Dependent Cytotoxicity upon Retargeting with a Bispecific Antibody
Bryan D. Choi et al.
CANCER IMMUNOLOGY RESEARCH (2013)
GITR Pathway Activation Abrogates Tumor Immune Suppression through Loss of Regulatory T-cell Lineage Stability
David A. Schaer et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells
Thomas Duhen et al.
BLOOD (2012)
A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
Daisuke Kawauchi et al.
CANCER CELL (2012)
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Hiroaki Wakimoto et al.
NEURO-ONCOLOGY (2012)
Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy
Courtney A. Crane et al.
NEURO-ONCOLOGY (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
David Coe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation
Adam D. Cohen et al.
PLOS ONE (2010)
Epigenetic control of T-helper-cell differentiation
Christopher B. Wilson et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Akt-Dependent Proapoptotic Effects of Dietary Restriction on Late-Stage Management of a Phosphatase and Tensin Homologue/Tuberous Sclerosis Complex 2-Deficient Mouse Astrocytoma
Jeremy Marsh et al.
CLINICAL CANCER RESEARCH (2008)
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance
Xuefang Cao et al.
IMMUNITY (2007)
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
Joseph El Khoury et al.
NATURE MEDICINE (2007)
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Jeong M. Kim et al.
NATURE IMMUNOLOGY (2007)
An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
Abdejabar El Andaloussi et al.
NEURO-ONCOLOGY (2006)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
K Ko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain
D Zagzag et al.
LABORATORY INVESTIGATION (2005)
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
ML Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+ CD25+ T cells
GL Stephens et al.
JOURNAL OF IMMUNOLOGY (2004)
分享论文
